|
Volumn 71, Issue 9, 2005, Pages 1753-1756
|
Fibroids (uterine myomatosis, leiomyomas).
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
LEUPRORELIN;
PREGNANE DERIVATIVE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
TIBOLONE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIFFERENTIAL DIAGNOSIS;
DRUG COMBINATION;
FEMALE;
GYNECOLOGIC SURGERY;
HUMAN;
LAPAROSCOPY;
LEIOMYOMA;
LEIOMYOMATOSIS;
METHODOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
UTERUS CANCER;
ANTINEOPLASTIC AGENTS, HORMONAL;
DIAGNOSIS, DIFFERENTIAL;
DRUG THERAPY, COMBINATION;
ESTROGEN RECEPTOR MODULATORS;
FEMALE;
GYNECOLOGIC SURGICAL PROCEDURES;
HUMANS;
LAPAROSCOPY;
LEIOMYOMA;
LEIOMYOMATOSIS;
LEUPROLIDE;
NORPREGNENES;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
UTERINE NEOPLASMS;
|
EID: 18744409098
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (20)
|
References (14)
|